The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort.
Philippa D K CurryGabriela Arredondo Hector ChinoyMeghna JaniDarren PlantKimmie L HyrichAnn W MorganAnthony G WilsonJohn Dudley IsaacsAndrew P MorrisRichard B WarrenJames BluettPublished in: The Journal of rheumatology (2023)
Suboptimal treatment adherence has been reported in patients with arthritic diseases; is associated with psychological factors, including anxiety; and correlates with future treatment response. 1,2 During the coronavirus disease 2019 (COVID-19) pandemic, patients who identified as clinically extremely vulnerable, including people prescribed ≥ 2 immunosuppressives, were advised to shield and continue treatment unless they developed COVID-19 symptoms.